Stock Market News

Amgen (AMGN) Announces Positive Results for Phase 3 Study of Bemarituzumab

wccwcc
Jul 7, 2025 - 05:00
 0  0
Amgen (AMGN) Announces Positive Results for Phase 3 Study of Bemarituzumab

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
wcc
wcc

Related Posts

Accenture plc (ACN) and Palantir (PLTR) Partner to Deliver AI Solutions

Accenture plc (ACN) and Palantir (PLTR) Partner to Deli...

wcc Jul 7, 2025  0  0

Wells Fargo Reduced the PT on Lowe’s Companies (LOW), Maintained a Buy Rating

Wells Fargo Reduced the PT on Lowe’s Companies (LOW), M...

wcc Jul 7, 2025  0  0

Diageo plc (DEO) Announces Completion of Sale of Its Shareholding in Seychelles Breweries Limited

Diageo plc (DEO) Announces Completion of Sale of Its Sh...

wcc Jul 7, 2025  0  0

FDA Grants Orphan Drug Designation To Sanofi’s (SNY) Riliprubart

FDA Grants Orphan Drug Designation To Sanofi’s (SNY) Ri...

wcc Jul 7, 2025  0  0

Chevron Corporation (CVX) Competing for Libya’s First Oil and Gas Exploration Tender

Chevron Corporation (CVX) Competing for Libya’s First O...

wcc Jul 7, 2025  0  0

Trump threatens extra 10% tariff on countries that align with 'Anti-American' BRICS policies

Trump threatens extra 10% tariff on countries that alig...

wcc Jul 7, 2025  0  0